Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases

Invest New Drugs. 1991 Nov;9(4):357-9. doi: 10.1007/BF00183581.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / secondary
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Drug Evaluation
  • Drug Interactions
  • Female
  • Humans
  • Hypoprothrombinemias / chemically induced*
  • Lung Neoplasms / blood
  • Lung Neoplasms / drug therapy*
  • Middle Aged
  • Ovarian Neoplasms / blood
  • Ovarian Neoplasms / drug therapy*
  • Sulfonylurea Compounds / administration & dosage*
  • Warfarin / administration & dosage*

Substances

  • Sulfonylurea Compounds
  • Warfarin
  • sulofenur